ARTICLE | Company News
Aeterna Zentaris, Merck KGaA deal
October 7, 2013 7:00 AM UTC
Aeterna completed the transfer of manufacturing rights for Cetrotide cetrorelix acetate in vitro fertilization (IVF) to marketing partner Merck Serono S.A., a division of Merck, in exchange for €2.5...